» Articles » PMID: 21151034

Innate Immune Mechanisms of Colitis and Colitis-associated Colorectal Cancer

Overview
Journal Nat Rev Immunol
Date 2010 Dec 15
PMID 21151034
Citations 202
Authors
Affiliations
Soon will be listed here.
Abstract

The innate immune system provides first-line defences in response to invading microorganisms and endogenous danger signals by triggering robust inflammatory and antimicrobial responses. However, innate immune sensing of commensal microorganisms in the intestinal tract does not lead to chronic intestinal inflammation in healthy individuals, reflecting the intricacy of the regulatory mechanisms that tame the inflammatory response in the gut. Recent findings suggest that innate immune responses to commensal microorganisms, although once considered to be harmful, are necessary for intestinal homeostasis and immune tolerance. This Review discusses recent findings that identify a crucial role for innate immune effector molecules in protection against colitis and colitis-associated colorectal cancer and the therapeutic implications that ensue.

Citing Articles

Gut microbiota in cancer initiation, development and therapy.

Zhang R, Zhang X, Lau H, Yu J Sci China Life Sci. 2025; .

PMID: 39821827 DOI: 10.1007/s11427-024-2831-x.


The Bidirectional Impact of Cancer Radiotherapy and Human Microbiome: Microbiome as Potential Anti-tumor Treatment Efficacy and Toxicity Modulator.

Palkovsky M, Modrackova N, Neuzil-Bunesova V, Liberko M, Soumarova R In Vivo. 2024; 39(1):37-54.

PMID: 39740900 PMC: 11705129. DOI: 10.21873/invivo.13803.


Inflammatory bowel disease, colitis, and cancer: unmasking the chronic inflammation link.

Shahgoli V, Noorolyai S, Ahmadpour Youshanlui M, Saeidi H, Nasiri H, Mansoori B Int J Colorectal Dis. 2024; 39(1):173.

PMID: 39465427 PMC: 11513726. DOI: 10.1007/s00384-024-04748-y.


The Gut Microbiota Impacts Gastrointestinal Cancers through Obesity, Diabetes, and Chronic Inflammation.

Rumyantsev K, Polyakova V, Sorokina I, Feoktistova P, Khatkov I, Bodunova N Life (Basel). 2024; 14(10).

PMID: 39459519 PMC: 11509742. DOI: 10.3390/life14101219.


Tocotrienol suppresses colitis-associated cancer progression through TLR4 signaling in a mouse model of colorectal cancer.

Li Q, Zhang S, Zhou Q, Gu C, Liu Y, Zhang J Curr Res Toxicol. 2024; 7:100196.

PMID: 39411685 PMC: 11474223. DOI: 10.1016/j.crtox.2024.100196.


References
1.
Penders J, Thijs C, Vink C, Stelma F, Snijders B, Kummeling I . Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics. 2006; 118(2):511-21. DOI: 10.1542/peds.2005-2824. View

2.
Turovskaya O, Foell D, Sinha P, Vogl T, Newlin R, Nayak J . RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis. Carcinogenesis. 2008; 29(10):2035-43. PMC: 2556970. DOI: 10.1093/carcin/bgn188. View

3.
de Silva S, Devlin S, Panaccione R . Optimizing the safety of biologic therapy for IBD. Nat Rev Gastroenterol Hepatol. 2010; 7(2):93-101. DOI: 10.1038/nrgastro.2009.221. View

4.
Noguchi E, Homma Y, Kang X, Netea M, Ma X . A Crohn's disease-associated NOD2 mutation suppresses transcription of human IL10 by inhibiting activity of the nuclear ribonucleoprotein hnRNP-A1. Nat Immunol. 2009; 10(5):471-9. PMC: 2928218. DOI: 10.1038/ni.1722. View

5.
Biswas A, Liu Y, Hao L, Mizoguchi A, Salzman N, Bevins C . Induction and rescue of Nod2-dependent Th1-driven granulomatous inflammation of the ileum. Proc Natl Acad Sci U S A. 2010; 107(33):14739-44. PMC: 2930434. DOI: 10.1073/pnas.1003363107. View